{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T05:29:20Z","timestamp":1745645360629,"version":"3.37.3"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T00:00:00Z","timestamp":1696291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Swedish Government"},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sk\u00e5ne University Hospital research funds and donations"},{"name":"MultiPark"},{"name":"The Swedish Parkinson Academy"},{"DOI":"10.13039\/501100021728","name":"Stiftelsen Bundy Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021728","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SCA Network"},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hereditary ataxia is a heterogeneous group of complex neurological disorders. Next-generation sequencing methods have become a great help in clinical diagnostics, but it may remain challenging to determine if a genetic variant is the cause of the patient\u2019s disease. We compiled a consecutive single-center series of 87 patients from 76 families with progressive ataxia of known or unknown etiology. We investigated them clinically and genetically using whole exome or whole genome sequencing. Test methods were selected depending on family history, clinical phenotype, and availability. Genetic results were interpreted based on the American College of Medical Genetics criteria. For high-suspicion variants of uncertain significance, renewed bioinformatical and clinical evaluation was performed to assess the level of pathogenicity. Thirty (39.5%) of the 76 families had received a genetic diagnosis at the end of our study. We present the predominant etiologies of hereditary ataxia in a Swedish patient series. In two families, we established a clinical diagnosis, although the genetic variant was classified as \u201cof uncertain significance\u201d only, and in an additional three families, results are pending. We found a pathogenic variant in one family, but we suspect that it does not explain the complete clinical picture. We conclude that correctly interpreting genetic variants in complex neurogenetic diseases requires genetics and clinical expertise. The neurologist\u2019s careful phenotyping remains essential to confirm or reject a diagnosis, also by reassessing clinical findings after a candidate genetic variant is suggested. Collaboration between neurology and clinical genetics and combining clinical and research approaches optimizes diagnostic yield.<\/jats:p>","DOI":"10.1007\/s00415-023-11990-x","type":"journal-article","created":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T05:02:26Z","timestamp":1696309346000},"page":"526-542","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7776-6691","authenticated-orcid":false,"given":"Sorina","family":"Gorcenco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efthymia","family":"Kafantari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Wallenius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christin","family":"Karremo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Alinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigurd","family":"Dobloug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Landqvist Wald\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Englund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Ehrencrona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klas","family":"Wictorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Karrman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Puschmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,3]]},"reference":[{"issue":"7","key":"11990_CR1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10072-019-03856-w","volume":"40","author":"M Lieto","year":"2019","unstructured":"Lieto M et al (2019) Degenerative and acquired sporadic adult onset ataxia. Neurol Sci 40(7):1335\u20131342","journal-title":"Neurol Sci"},{"issue":"4","key":"11990_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/jnnp-2016-314863","volume":"88","author":"M Hadjivassiliou","year":"2017","unstructured":"Hadjivassiliou M et al (2017) Causes of progressive cerebellar ataxia: prospective evaluation of 1500 patients. J Neurol Neurosurg Psychiatry 88(4):301\u2013309","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11990_CR3","first-page":"1312","volume":"19","author":"M Pandolfo","year":"2013","unstructured":"Pandolfo M, Manto M (2013) Cerebellar and afferent ataxias. Continuum (Minneap Minn) 19:1312\u20131343","journal-title":"Continuum (Minneap Minn)"},{"key":"11990_CR4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.parkreldis.2020.02.015","volume":"73","author":"S Gorcenco","year":"2020","unstructured":"Gorcenco S et al (2020) New generation genetic testing entering the clinic. Parkinsonism Relat Disord 73:72\u201384","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"11990_CR5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaneurol.2013.1707","volume":"70","author":"P Coutinho","year":"2013","unstructured":"Coutinho P et al (2013) Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study. JAMA Neurol 70(6):746\u2013755","journal-title":"JAMA Neurol"},{"issue":"3","key":"11990_CR6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000358801","volume":"42","author":"L Ruano","year":"2014","unstructured":"Ruano L et al (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42(3):174\u2013183","journal-title":"Neuroepidemiology"},{"key":"11990_CR7","first-page":"73","volume-title":"Handbook of clinical neurology","author":"M Synofzik","year":"2018","unstructured":"Synofzik M, N\u00e9meth AH (2018) Recessive ataxias. In: Manto M, Huisman TAGM (eds) Handbook of clinical neurology. Elsevier, pp 73\u201389"},{"issue":"6","key":"11990_CR8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/brain\/awx081","volume":"140","author":"M Coutelier","year":"2017","unstructured":"Coutelier M et al (2017) A panel study on patients with dominant cerebellar ataxia highlights the frequency of channelopathies. Brain 140(6):1579\u20131594","journal-title":"Brain"},{"issue":"3","key":"11990_CR9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/mdc3.13163","volume":"8","author":"R Gannamani","year":"2021","unstructured":"Gannamani R et al (2021) Challenges in clinicogenetic correlations: one phenotype - many genes. Mov Disord Clin Pract 8(3):311\u2013321","journal-title":"Mov Disord Clin Pract"},{"issue":"8","key":"11990_CR10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.parkreldis.2014.04.018","volume":"20","author":"E Ygland","year":"2014","unstructured":"Ygland E et al (2014) Atypical Friedreich ataxia in patients with FXN p.R165P point mutation or comorbid hemochromatosis. Parkinsonism Relat Disord 20(8):919\u2013923","journal-title":"Parkinsonism Relat Disord"},{"key":"11990_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s12311-022-01505-1","author":"S Gorcenco","year":"2022","unstructured":"Gorcenco S, Karremo C, Puschmann A (2022) Patients\u2019 perspective in hereditary ataxia. Cerebellum. https:\/\/doi.org\/10.1007\/s12311-022-01505-1","journal-title":"Cerebellum"},{"issue":"11","key":"11990_CR12","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-H\u00fcbsch","year":"2006","unstructured":"Schmitz-H\u00fcbsch T et al (2006) Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 66(11):1717\u20131720","journal-title":"Neurology"},{"issue":"566","key":"11990_CR13","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb7086","volume":"12","author":"M Prudencio","year":"2020","unstructured":"Prudencio M et al (2020) Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3. Sci Transl Med 12(566):eabb7086","journal-title":"Sci Transl Med"},{"issue":"8","key":"11990_CR14","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1111\/ene.15373","volume":"29","author":"H Garcia-Moreno","year":"2022","unstructured":"Garcia-Moreno H et al (2022) Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3. Eur J Neurol 29(8):2439\u20132452","journal-title":"Eur J Neurol"},{"issue":"3","key":"11990_CR15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M et al (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310\u2013315","journal-title":"Nat Genet"},{"issue":"1","key":"11990_CR16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41467-017-00141-2","volume":"8","author":"S Gelfman","year":"2017","unstructured":"Gelfman S et al (2017) Annotating pathogenic non-coding variants in genic regions. Nat Commun 8(1):236","journal-title":"Nat Commun"},{"issue":"5","key":"11990_CR17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004962","volume":"12","author":"J Bendl","year":"2016","unstructured":"Bendl J et al (2016) PredictSNP2: a unified platform for accurately evaluating SNP effects by exploiting the different characteristics of variants in distinct genomic regions. PLoS Comput Biol 12(5):e1004962","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"11990_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40246-023-00451-1","volume":"17","author":"JM de Sainte Agathe","year":"2023","unstructured":"de Sainte Agathe JM et al (2023) SpliceAI-visual: a free online tool to improve SpliceAI splicing variant interpretation. Hum Genom 17(1):7","journal-title":"Hum Genom"},{"issue":"13","key":"11990_CR19","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/bioinformatics\/btv112","volume":"31","author":"A Tan","year":"2015","unstructured":"Tan A, Abecasis GR, Kang HM (2015) Unified representation of genetic variants. Bioinformatics 31(13):2202\u20132204","journal-title":"Bioinformatics"},{"issue":"11","key":"11990_CR20","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ejhg.2017.130","volume":"25","author":"A Ameur","year":"2017","unstructured":"Ameur A et al (2017) SweGen: a whole-genome data resource of genetic variability in a cross-section of the Swedish population. Eur J Hum Genet 25(11):1253\u20131260","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"11990_CR21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424","journal-title":"Genet Med"},{"issue":"11","key":"11990_CR22","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C et al (2019) VarSome: the human genomic variant search engine. Bioinformatics 35(11):1978\u20131980","journal-title":"Bioinformatics"},{"issue":"1","key":"11990_CR23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s40478-021-01201-x","volume":"9","author":"SR Chintalaphani","year":"2021","unstructured":"Chintalaphani SR et al (2021) An update on the neurological short tandem repeat expansion disorders and the emergence of long-read sequencing diagnostics. Acta Neuropathol Commun 9(1):98","journal-title":"Acta Neuropathol Commun"},{"issue":"21","key":"11990_CR24","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/bioinformatics\/bts526","volume":"28","author":"V Plagnol","year":"2012","unstructured":"Plagnol V et al (2012) A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics 28(21):2747\u20132754","journal-title":"Bioinformatics"},{"issue":"5","key":"11990_CR25","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000183","volume":"3","author":"S Gorcenco","year":"2017","unstructured":"Gorcenco S et al (2017) Ataxia-pancytopenia syndrome with SAMD9L mutations. Neurol Genet 3(5):e183","journal-title":"Neurol Genet"},{"key":"11990_CR26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2018.10.017","volume":"61","author":"S Gorcenco","year":"2019","unstructured":"Gorcenco S et al (2019) Oral therapy for riboflavin transporter deficiency - What is the regimen of choice? Parkinsonism Relat Disord 61:245\u2013247","journal-title":"Parkinsonism Relat Disord"},{"issue":"6","key":"11990_CR27","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajhg.2016.04.009","volume":"98","author":"DH Chen","year":"2016","unstructured":"Chen DH et al (2016) Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L. Am J Hum Genet 98(6):1146\u20131158","journal-title":"Am J Hum Genet"},{"issue":"4","key":"11990_CR28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2013.6337","volume":"71","author":"M Cadieux-Dion","year":"2014","unstructured":"Cadieux-Dion M et al (2014) Expanding the clinical phenotype associated with ELOVL4 Mutation: study of a large French\u2013Canadian family with autosomal dominant spinocerebellar ataxia and erythrokeratodermia. JAMA Neurol 71(4):470\u2013475","journal-title":"JAMA Neurol"},{"issue":"7","key":"11990_CR29","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2015.0610","volume":"72","author":"K Ozaki","year":"2015","unstructured":"Ozaki K et al (2015) A novel mutation in ELOVL4 leading to spinocerebellar ataxia (SCA) with the hot cross bun sign but lacking erythrokeratodermia: a broadened spectrum of SCA34. JAMA Neurol 72(7):797\u2013805","journal-title":"JAMA Neurol"},{"issue":"2","key":"11990_CR30","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000403","volume":"6","author":"M Beaudin","year":"2020","unstructured":"Beaudin M et al (2020) Characterization of the phenotype with cognitive impairment and protein mislocalization in SCA34. Neurol Genet 6(2):e403","journal-title":"Neurol Genet"},{"issue":"6","key":"11990_CR31","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.ajhg.2016.04.003","volume":"98","author":"GP Jarvik","year":"2016","unstructured":"Jarvik GP, Browning BL (2016) Consideration of cosegregation in the pathogenicity classification of genomic variants. Am J Hum Genet 98(6):1077\u20131081","journal-title":"Am J Hum Genet"},{"issue":"3","key":"11990_CR32","volume":"6","author":"MO Mol","year":"2020","unstructured":"Mol MO et al (2020) Clinical and pathologic phenotype of a large family with heterozygous STUB1 mutation. Neurol Genet 6(3):e417","journal-title":"Neurol Genet"},{"issue":"2","key":"11990_CR33","first-page":"1","volume":"6","author":"DH Chen","year":"2020","unstructured":"Chen DH et al (2020) Heterozygous STUB1 missense variants cause ataxia, cognitive decline, and STUB1 mislocalization. Neurol Genet 6(2):1\u201313","journal-title":"Neurol Genet"},{"issue":"5","key":"11990_CR34","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00415-020-10348-x","volume":"268","author":"J-M Ravel","year":"2021","unstructured":"Ravel J-M et al (2021) Expanding the clinical spectrum of STIP1 homology and U-box containing protein 1-associated ataxia. J Neurol 268(5):1927\u20131937","journal-title":"J Neurol"},{"issue":"6","key":"11990_CR35","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ajhg.2016.05.009","volume":"98","author":"Z Gan-Or","year":"2016","unstructured":"Gan-Or Z et al (2016) Mutations in CAPN1 cause autosomal-recessive hereditary spastic paraplegia. Am J Hum Genet 98(6):1271","journal-title":"Am J Hum Genet"},{"issue":"4","key":"11990_CR36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41588-019-0372-4","volume":"51","author":"A Cortese","year":"2019","unstructured":"Cortese A et al (2019) Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet 51(4):649\u2013658","journal-title":"Nat Genet"},{"issue":"12","key":"11990_CR37","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/s41436-020-0917-z","volume":"22","author":"H Findlay Black","year":"2020","unstructured":"Findlay Black H et al (2020) Frequency of the loss of CAA interruption in the HTT CAG tract and implications for Huntington disease in the reduced penetrance range. Genet Med 22(12):2108\u20132113","journal-title":"Genet Med"},{"issue":"1","key":"11990_CR38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/practneurol-2021-003074","volume":"22","author":"TB Stoker","year":"2022","unstructured":"Stoker TB et al (2022) Huntington\u2019s disease: diagnosis and management. Pract Neurol 22(1):32\u201341","journal-title":"Pract Neurol"},{"issue":"1","key":"11990_CR39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ajhg.2020.12.002","volume":"108","author":"D Djordjevic","year":"2021","unstructured":"Djordjevic D et al (2021) De novo variants in POLR3B cause ataxia, spasticity, and demyelinating neuropathy. Am J Hum Genet 108(1):186\u2013193","journal-title":"Am J Hum Genet"},{"issue":"1","key":"11990_CR40","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12311-017-0885-2","volume":"17","author":"MS Salman","year":"2018","unstructured":"Salman MS (2018) Epidemiology of cerebellar diseases and therapeutic approaches. The Cerebellum 17(1):4\u201311","journal-title":"The Cerebellum"},{"issue":"1","key":"11990_CR41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12883-021-02409-z","volume":"21","author":"J Lipponen","year":"2021","unstructured":"Lipponen J et al (2021) Molecular epidemiology of hereditary ataxia in Finland. BMC Neurol 21(1):382","journal-title":"BMC Neurol"},{"issue":"3","key":"11990_CR42","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/mds.26944","volume":"32","author":"M Synofzik","year":"2017","unstructured":"Synofzik M, Sch\u00fcle R (2017) Overcoming the divide between ataxias and spastic paraplegias: shared phenotypes, genes, and pathways. Mov Disord 32(3):332\u2013345","journal-title":"Mov Disord"},{"key":"11990_CR43","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.571843","volume":"11","author":"GL Franklin","year":"2020","unstructured":"Franklin GL et al (2020) Is ataxia an underestimated symptom of Huntington\u2019s disease? Front Neurol 11:571843","journal-title":"Front Neurol"},{"issue":"7","key":"11990_CR44","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrg3455","volume":"14","author":"DB Goldstein","year":"2013","unstructured":"Goldstein DB et al (2013) Sequencing studies in human genetics: design and interpretation. Nat Rev Genet 14(7):460\u2013470","journal-title":"Nat Rev Genet"},{"issue":"1","key":"11990_CR45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gim.2021.08.003","volume":"24","author":"S Magri","year":"2022","unstructured":"Magri S et al (2022) Digenic inheritance of STUB1 variants and TBP polyglutamine expansions explains the incomplete penetrance of SCA17 and SCA48. Genet Med 24(1):29\u201340","journal-title":"Genet Med"},{"issue":"4","key":"11990_CR46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/mds.29352","volume":"38","author":"L Nanetti","year":"2023","unstructured":"Nanetti L et al (2023) Complex ataxia-dementia phenotype in patients with digenic TBP\/STUB1 spinocerebellar ataxia. Mov Disord 38(4):665\u2013675","journal-title":"Mov Disord"},{"issue":"2","key":"11990_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.10.009","volume":"25","author":"M Barbier","year":"2023","unstructured":"Barbier M et al (2023) Intermediate repeat expansions of TBP and STUB1: genetic modifier or pure digenic inheritance in spinocerebellar ataxias? Genet Med 25(2):100327","journal-title":"Genet Med"},{"issue":"4","key":"11990_CR48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/humu.22956","volume":"37","author":"S Moghadasi","year":"2016","unstructured":"Moghadasi S et al (2016) Classification and clinical management of variants of uncertain significance in high penetrance cancer predisposition genes. Hum Mutat 37(4):331\u2013336","journal-title":"Hum Mutat"},{"issue":"6","key":"11990_CR49","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002169","volume":"11","author":"A Morales","year":"2018","unstructured":"Morales A, Hershberger RE (2018) Variants of uncertain significance: should we revisit how they are evaluated and disclosed? Circ Genom Precis Med 11(6):e002169","journal-title":"Circ Genom Precis Med"},{"issue":"16","key":"11990_CR50","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","volume":"129","author":"B Tesi","year":"2017","unstructured":"Tesi B et al (2017) Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms. Blood 129(16):2266\u20132279","journal-title":"Blood"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11990-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11990-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11990-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T16:16:19Z","timestamp":1704471379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11990-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["11990"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11990-x","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[2023,10,3]]},"assertion":[{"value":"16 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Written and informed consent was obtained from all individual participants included in the study. Our study was ethically approved by the Regional Ethics Review Board responsible for Region Sk\u00e5ne (Dnr.2013\/516) and the Swedish Ethical Review Authority (Dnr. 2021\u201300884).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}